We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-2.89%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$935M
AUM Growth
+$227M
Cap. Flow
+$310M
Cap. Flow %
33.15%
Top 10 Hldgs %
70.78%
Holding
86
New
20
Increased
18
Reduced
12
Closed
29

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$32.9M
2
LLY icon
Eli Lilly
LLY
+$18.6M
3
FIVN icon
FIVE9
FIVN
+$11.3M
4
NICE icon
Nice
NICE
+$11.2M
5
META icon
Meta Platforms (Facebook)
META
+$9.65M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$26.7M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$16.3M
3
KYMR icon
Kymera Therapeutics
KYMR
+$15.6M
4
ZIM icon
ZIM Integrated Shipping Services
ZIM
+$10.8M
5
GNRC icon
Generac Holdings
GNRC
+$9.81M

Sector Composition

Rank Sector Weight
1 Healthcare 47.28%
2 Technology 3.05%
3 Communication Services 0.86%
4 Financials 0.27%
5 Consumer Discretionary 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOLD
26
DELISTED
Amicus Therapeutics
FOLD
$8.09M 0.87%
+753,037
New +$6.2M
META icon
27
Meta Platforms (Facebook)
META
$1.42T
$8.06M 0.86%
+50,000
New +$9.65M
IMTX icon
28
Immatics
IMTX
$1.18B
$6.37M 0.68%
730,712
+108,787
+17% +$861K
INZY
29
DELISTED
Inozyme Pharma
INZY
$5.56M 0.59%
+1,165,600
New +$5.07M
CCCC icon
30
C4 Therapeutics
CCCC
$385M
$5.32M 0.57%
705,736
+343,208
+95% +$3.02M
RZLT icon
31
Rezolute
RZLT
$454M
$3.73M 0.4%
+1,155,897
New +$3.84M
VTGN icon
32
VistaGen Therapeutics
VTGN
$9.89M
$2.9M 0.31%
109,705
-55,342
-34% -$1.95M
CNCE
33
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2.86M 0.31%
+679,400
New +$2.69M
RIGL icon
34
Rigel Pharmaceuticals
RIGL
$681M
$2.85M 0.31%
+252,500
New +$5.07M
PMVP icon
35
PMV Pharmaceuticals
PMVP
$59.2M
$2.68M 0.29%
+187,800
New +$2.73M
V icon
36
Visa
V
$684B
$2.48M 0.27%
12,600
-12,600
-50% -$2.6M
KZR
37
DELISTED
Kezar Life Sciences
KZR
$2.48M 0.27%
29,965
+11,205
+60% +$988K
ABNB icon
38
Airbnb
ABNB
$89.9B
$2.47M 0.26%
27,700
-2,300
-8% -$299K
HOWL icon
39
Werewolf Therapeutics
HOWL
$17.2M
$2.44M 0.26%
597,003
+12,800
+2% +$58.4K
QQQ icon
40
Invesco QQQ Trust
QQQ
$453B
$2.29M 0.25%
+8,186
New +$2.54M
ISEE
41
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.92M 0.21%
+200,000
New +$2.51M
KROS icon
42
Keros Therapeutics
KROS
$199M
$1.88M 0.2%
67,997
-71,584
-51% -$3.14M
NVDA icon
43
NVIDIA
NVDA
$4.86T
$1.71M 0.18%
+112,880
New +$2.13M
ETNB
44
DELISTED
89bio
ETNB
$1.45M 0.16%
+450,000
New +$1.36M
MGIC
45
DELISTED
Magic Software Enterprises
MGIC
$1.45M 0.15%
81,293
– –
VTGN icon
46
CALL
VistaGen Therapeutics
VTGN
$9.89M
$1.32M 0.14%
+50,000
New +$1.77M
AMD icon
47
Advanced Micro Devices
AMD
$776B
$1.21M 0.13%
15,773
-84,227
-84% -$7.88M
KNTE
48
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$1.16M 0.12%
+91,673
New +$853K
ONCR
49
DELISTED
Oncorus, Inc.
ONCR
$681K 0.07%
540,258
– –
GNRC icon
50
Generac Holdings
GNRC
$11.6B
$486K 0.05%
2,310
-39,901
-95% -$9.81M
1
2
3 4

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2022 Portfolio in Review

As of Q2 2022, Sphera Funds Management held 86 positions worth $935M, up 32% from $708M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Sphera Funds Management deployed $310M of net new capital in Q2 2022, opening 20 new positions and adding to 18 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 437,748 shares worth $32.5M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 72% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Generac Holdings, an estimated $9.81M trimmed.

  • Sphera Funds Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 437,748 shares worth $32.5M.
  • Sphera Funds Management added most to Eli Lilly in Q2 2022, an estimated $18.6M increase.
  • Sphera Funds Management's biggest Q2 2022 reduction was Generac Holdings, cutting an estimated $9.81M.
  • Sphera Funds Management fully exited Pfizer in Q2 2022, selling an estimated $26.7M.
  • Sphera Funds Management's ten largest holdings make up 71% of its $935M portfolio in Q2 2022.
  • Sphera Funds Management opened 20 new positions and closed 29 in Q2 2022.
  • Sphera Funds Management's portfolio value rose 32% quarter-over-quarter to $935M.

Based on Sphera Funds Management's 13F filing for Q2 2022, filed 15 Aug 2022.